Pinnacle West Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.92M Sell
4,256
-125
-3% -$127K 2.66% 5
2025
Q4
$4.71M Sell
4,381
-40
-0.9% -$38.2K 3.06% 4
2025
Q3
$3.37M Buy
4,421
+13
+0.3% +$9.67K 2.18% 9
2025
Q2
$3.44M Sell
4,408
-23
-0.5% -$17.9K 2.38% 7
2025
Q1
$3.66M Buy
4,431
+6
+0.1% +$4.99K 2.64% 6
2024
Q4
$3.42M Sell
4,425
-120
-3% -$99.4K 2.45% 8
2024
Q3
$4.03M Sell
4,545
-5
-0.1% -$4.5K 2.89% 4
2024
Q2
$4.12M Sell
4,550
-15
-0.3% -$12K 3.2% 4
2024
Q1
$3.55M Sell
4,565
-5
-0.1% -$3.56K 2.82% 3
2023
Q4
$2.66M Buy
4,570
+25
+0.6% +$14.6K 2.28% 8
2023
Q3
$2.44M Buy
4,545
+95
+2% +$49K 2.39% 6
2023
Q2
$2.09M Sell
4,450
-30
-0.7% -$12.6K 2.03% 8
2023
Q1
$1.54M Buy
+4,480
New +$1.51M 1.61% 12

Other funds holding LLY

Pinnacle West Asset Management's LLY Position: Q1 2026 in Review

Pinnacle West Asset Management reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2026, selling an estimated $127K and leaving 4,256 shares worth $3.92M. The position accounts for 2.66% of the portfolio, ranked #5.

Pinnacle West Asset Management first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $4.71M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pinnacle West Asset Management held 4,256 shares of Eli Lilly worth $3.92M as of Q1 2026.
  • Pinnacle West Asset Management sold 125 Eli Lilly shares in Q1 2026, an estimated $127K.
  • Eli Lilly made up 2.66% of Pinnacle West Asset Management's portfolio in Q1 2026, its #5 holding.
  • Pinnacle West Asset Management first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • Pinnacle West Asset Management's Eli Lilly position peaked at $4.71M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pinnacle West Asset Management's 13F filing for Q1 2026, filed 15 May 2026.